Yellow Plaques on Skin (Xanthomas)

What is Yellow Plaques on Skin (Xanthomas)?

Xanthomas are firm, yellow‑to‑orange colored plaques or nodules that develop in the skin or tendons. The word comes from the Greek xanthos, meaning “yellow.” They form when lipids (fats) accumulate inside specialized cells called macrophages, creating visible deposits beneath the surface of the skin. Xanthomas are not infections or allergic reactions; they are a cutaneous sign that often points to an underlying metabolic or systemic disorder.

Although most xanthomas are benign, they can be a clue to serious conditions such as high cholesterol, diabetes, or even rare genetic lipid disorders. Recognizing them early can lead to timely investigation and treatment of the root cause.

Common Causes

Below are the most frequent conditions associated with yellow plaques on the skin. Many of these share a common thread—abnormal lipid metabolism.

• Familial hypercholesterolemia (FH): An inherited defect in LDL‑receptor function causing very high LDL‑cholesterol levels.
• Familial combined hyperlipidemia: Elevated LDL, VLDL, and triglycerides due to genetic and environmental factors.
• Type IIa dyslipidemia (primary hypercholesterolemia): High LDL with normal triglycerides.
• Type III dyslipoproteinemia (Familial dysbetalipoproteinemia): Impaired clearance of remnant particles, leading to broad‑based xanthomas.
• Type IV hypertriglyceridemia: Very high triglycerides that can produce eruptive xanthomas.
• Diabetes mellitus: Poorly controlled diabetes can cause eruptive xanthomas and xanthelasmas.
• Liver disease (e.g., primary biliary cholangitis, cirrhosis): Altered lipid metabolism may produce xanthomas.
• Kidney disease (nephrotic syndrome): Massive protein loss leads to hyperlipidemia and eruptive xanthomas.
• Medication‑induced lipid changes: Certain drugs (e.g., cyclosporine, retinoids, estrogen therapy) can raise lipid levels.
• Rare genetic disorders: Sitosterolemia, cerebrotendinous xanthomatosis, and others cause xanthomas through abnormal sterol metabolism.

Associated Symptoms

While xanthomas themselves are usually painless, they often appear alongside other clinical features that reflect the underlying disease:

• Fatigue or weakness (common in severe hyperlipidemia or diabetes).
• Chest pain or shortness of breath – possible early signs of atherosclerotic heart disease.
• Abdominal discomfort or pancreatitis – especially with very high triglycerides.
• Eye changes such as xanthelasma on the eyelids.
• Joint pain or swelling if tendinous xanthomas affect the Achilles or extensor tendons.
• Yellowish deposits on the palms, elbows, or knees (tuberous or planar xanthomas).
• Family history of premature heart attack, stroke, or known lipid disorder.

When to See a Doctor

Because xanthomas can be the first visible sign of dangerous metabolic disease, prompt evaluation is crucial. Seek medical attention if you notice:

• New yellow plaques that are growing or spreading.
• Any accompanying chest pain, shortness of breath, or sudden weakness.
• Recurring abdominal pain that could indicate pancreatitis.
• Sudden changes in vision or eye discomfort.
• A personal or family history of high cholesterol, heart disease, or early‑onset stroke.
• Signs of diabetes (excessive thirst, frequent urination, unexplained weight loss).

Diagnosis

Diagnosis is a stepwise process that combines a visual skin examination with laboratory and imaging studies.

1. Clinical Examination

• Dermatologic assessment of size, location, and type of xanthoma (eruptive, tuberous, tendinous, planar).
• Evaluation for other skin signs such as xanthelasma or cholesterol deposits around the eyes.

2. Laboratory Tests

• Lipid panel: Total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Blood glucose & HbA1c: Screen for diabetes.
• Liver function tests (ALT, AST, GGT): Detect hepatic contribution.
• Kidney function (creatinine, urine protein): Rule out nephrotic syndrome.
• Genetic testing for familial hypercholesterolemia or rare lipid disorders when a hereditary cause is suspected.

3. Imaging & Other Studies

• Ultrasound or CT of the abdomen to look for fatty liver or pancreatic inflammation.
• Echocardiogram or coronary calcium scoring if cardiovascular risk is high.
• Skin biopsy (rarely needed) showing lipid‑laden foam cells confirms the diagnosis.

4. Specialist Referral

Depending on findings, patients may be referred to a lipidologist, endocrinologist, hepatologist, or dermatologist for further management.

Treatment Options

Treatment aims at two levels: removing or reducing the visible plaques and, more importantly, correcting the underlying metabolic disturbance.

1. Lifestyle Modifications

• Diet: Adopt a heart‑healthy diet rich in vegetables, fruits, whole grains, and lean protein; limit saturated fat, trans‑fat, and simple sugars. The Mediterranean diet is evidence‑based for lowering LDL and triglycerides.
• Physical activity: At least 150 minutes of moderate aerobic exercise per week improves lipid profile and insulin sensitivity.
• Weight management: Losing 5‑10 % of body weight can markedly reduce triglyceride levels and eruptive xanthomas.
• Alcohol moderation: Excess alcohol raises triglycerides and may precipitate pancreatitis.
• Smoking cessation: Smoking accelerates atherosclerosis, the primary long‑term risk of xanthomas.

2. Medications

• Statins (e.g., atorvastatin, rosuvastatin): First‑line for lowering LDL‑C; can also modestly reduce triglycerides.
• Ezetimibe: Blocks intestinal cholesterol absorption, useful when statins alone are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab): Highly effective in familial hypercholesterolemia resistant to statins.
• Fibrates (fenofibrate, gemfibrozil): Primarily lower triglycerides and may shrink eruptive xanthomas.
• Omega‑3 fatty acid supplements (EPA/DHA): Reduce very high triglycerides.
• Niacin: Can improve HDL‑C but limited by side effects; used less often now.
• Insulin or oral hypoglycemics: For patients with diabetes, achieving glycemic control aids lipid normalization.

3. Direct Plaque Management

• Observation: In many cases, plaques regress once lipid levels are controlled.
• Cryotherapy or laser therapy: Cosmetic removal for persistent plaques after metabolic control.
• Surgical excision: Rarely required, reserved for large tendinous xanthomas that limit mobility.

4. Monitoring

Regular follow‑up labs (lipid panel every 3–6 months) and clinical skin checks are essential to gauge treatment response and adjust therapy accordingly.

Prevention Tips

While not all causes are preventable (e.g., genetic lipid disorders), many modifiable risk factors can reduce the likelihood of developing xanthomas:

• Maintain a balanced, low‑saturated‑fat diet from childhood.
• Stay physically active most days of the week.
• Keep a healthy body weight; aim for a BMI < 25 kg/m² when possible.
• Get routine lipid screening—starting at age 20 for the general public and earlier for those with a family history.
• Control blood sugar through diet, exercise, and medication if diagnosed with diabetes.
• Limit alcohol intake to ≤ 1 drink per day for women and ≤ 2 drinks per day for men.
• Avoid tobacco products.
• Discuss any new medications with a pharmacist or physician for potential lipid‑raising side effects.

Emergency Warning Signs

If you experience any of the following, seek immediate medical attention (go to the emergency department or call emergency services):

• Sudden, severe chest pain or pressure that may radiate to the arm, neck, or jaw.
• Acute shortness of breath, especially if accompanied by swelling of the legs.
• Severe abdominal pain with vomiting, which could signal pancreatitis.
• Rapid onset of neurological symptoms such as slurred speech, weakness on one side of the body, or loss of vision.
• Sudden swelling or pain in a limb where a tendinous xanthoma is located, suggesting possible tendon rupture.

References

• Mayo Clinic. “Xanthomas: Causes, symptoms & treatment.” https://www.mayoclinic.org
• National Heart, Lung, & Blood Institute (NHLBI). “Familial Hypercholesterolemia.” https://www.nhlbi.nih.gov
• Cleveland Clinic. “Eruptive Xanthomas.” https://my.clevelandclinic.org
• American Diabetes Association. “Standards of Care in Diabetes—2024.” https://diabetes.org
• World Health Organization. “Noncommunicable diseases: Lipid disorders.” https://www.who.int
• Journal of the American College of Cardiology. “PCSK9 Inhibitors for Familial Hypercholesterolemia.” 2023;81(9):902‑915.